Study Finds Genetic Link Between Weight Loss Drugs and Male Hair Loss Risk
A new peer-reviewed study from NYU Langone Health links weight loss drugs like Ozempic, Wegovy, and Zepbound to a 7% increased risk of male pattern hair loss in genetically predisposed men. The research identifies a genetic connection involving the GLP1R gene and androgenetic alopecia, independent of factors like hypertension, insulin resistance, or testosterone levels. While hair thinning has been attributed to rapid weight loss from these drugs, this study is the first to establish a genetic association with GLP-1 activity.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 57/100.
Outlets measured: news18, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 5 Sept, 11:36 am. Other outlets followed.
- 1